Bangue, Daisy Joy .

HRN: 11-49-08  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/03/2023
CEFOTAXIME 500MG (VIAL)
04/03/2023
04/09/2023
ORAL
500mg
BID
S/P NSVD With RMLE And Repair Thickly Meconium Stained
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Non-compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: